相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
James A. McKinnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007)
Joseph L. Kuti et al.
INFECTIOUS DISEASES AND THERAPY (2019)
Can Nebulised Colistin Therapy Improve Outcomes in Critically Ill Children with Multi-Drug Resistant Gram-Negative Bacterial Pneumonia?
Fatih Aygun et al.
ANTIBIOTICS-BASEL (2019)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae
Mohamed Farouk Ahmed Abdelsalam et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Alexandre P. Zavascki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
MCR: modern colistin resistance
I. Caniaux et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2016)
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
A. Capone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens
Philip E. Grgurich et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2012)
Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa
Reinout Naesens et al.
BMC INFECTIOUS DISEASES (2011)
Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
W. Couet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
Argyris S. Michalopoulos et al.
ANNALS OF INTENSIVE CARE (2011)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: A case series
Matthew E. Falagas et al.
RESPIRATORY MEDICINE (2009)
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients:: first report of a multiclonal cluster
Anastasia Antoniadou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Scale for the assessment and rating of ataxia -: Development of a new clinical scale
T. Schmitz-Huebsch et al.
NEUROLOGY (2006)
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
D Berlana et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2005)